BioregulatorModerate Evidence✦ Khavinson Bioregulator

Retinalamin

Also known as: Retinal bioregulator

Khavinson retinal bioregulator that regulates retinal gene expression and visual function.

Evidence

Moderate

FDA status

Not FDA-approved

Source

Retinal tissue-derived peptide bioregulator

Overview

Khavinson retinal bioregulator that regulates retinal gene expression and visual function.

Mechanism of Action

Organ-specific bioregulator for retinal tissue, modulates gene expression in photoreceptors and retinal cells, supports retinal regeneration, protects against oxidative damage, enhances visual function.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Retinal health
  • Visual function improvement
  • Photoreceptor protection
  • Reduces retinal degeneration
  • Supports night vision
  • Anti-aging for eyes

Researched for

Research topics, not approved uses.

Macular degenerationDiabetic retinopathyRetinitis pigmentosaGlaucoma (support)Age-related vision declineRetinal damage

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. Retinalamin isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Moderate
Studies

Russian clinical trials, approved pharmaceutical

Summary

Approved in Russia for some eye diseases. Most studies come from Russian groups and have not been confirmed by independent trials elsewhere.

Safety Information

Potential Side Effects

  • •Injection site reactions
  • •Few systemic effects reported

Contraindications

  • Pregnancy
  • Breastfeeding
  • Eye infections

Interactions

  • ⚠May complement ophthalmologic treatments

Quick Facts

CategoryBioregulator
SourceRetinal tissue-derived peptide bioregulator
StatusApproved pharmaceutical in Russia; research compound elsewhere